A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
Clinical trial NCT05945927 · COMPLETED
Trial details
- NCT number
- NCT05945927
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-13
- Primary completion
- 2025-08-30
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.